+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tacrolimus Test"

2021 Tacrolimus Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2021 Tacrolimus Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2021
  • Japan, United States, ... Japan, United States, Europe
From
2020 Tacrolimus Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Tacrolimus Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • February 2020
  • Japan, United States, ... Japan, United States, Europe
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Tacrolimus Test is an in vitro diagnostic (IVD) used to measure the amount of tacrolimus in a patient's blood. It is used to monitor the effectiveness of immunosuppressive therapy in organ transplant patients. The test is also used to diagnose and monitor the progression of certain autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. The Tacrolimus Test market is a rapidly growing segment of the IVD industry. It is driven by the increasing prevalence of organ transplantation and autoimmune diseases, as well as the need for accurate and reliable monitoring of immunosuppressive therapy. The market is expected to benefit from the development of new technologies and the introduction of novel products. Some of the major companies in the Tacrolimus Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, and Beckman Coulter. Show Less Read more